已收盘 02-06 16:00:00 美东时间
+0.110
+5.19%
On January 26, 2026, F.H. Investments, Inc. ("Asteria Health"), a 503B manufacturer of compounded bioidentical hormones and wholly-owned subsidiary of biote Corp. (the "Company"), out of an abundance of caution initiated
01-27 06:27
Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $190.000 million to $190.000 million vs $192.670 million estimate.
2025-11-06 05:19
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 33.33 percent decrease over earnings of $0.33 per share from the same
2025-11-06 05:19
Biote shares are trading lower after the company reported mixed Q2 financial re...
2025-08-07 05:33
biote ( ($BTMD) ) just unveiled an update. On June 2, 2025, Steven J. Heyer res...
2025-06-05 20:46
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 durin...
2025-05-28 05:06
Shares of Meta Platforms, Inc. (NASDAQ:META) rose sharply in pre-market trading...
2025-05-01 17:17
biote ( ($BTMD) ) has provided an update. On April 1, 2025, Marc Beer, Executiv...
2025-04-25 04:54
biote (NASDAQ:BTMD) said on Tuesday that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of the company's common stock, acquiring an aggrega...
2025-03-19 05:47
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107226114384474112.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity:维持Zevra Therapeutics(ZVRA)"买入"评级,目标价从23美元升至25美元</p> <p>• Benchmark:维持E W Scripps(SSP)"买入"评级,目
2025-03-14 09:45